Exploring Causal Associations Between Serum Inflammatory Markers and Female Reproductive Disorders: A Mendelian Randomisation Study

Biomolecules. 2024 Dec 2;14(12):1544. doi: 10.3390/biom14121544.

Abstract

Although inflammation may disrupt immunoendocrine crosstalk essential for female reproductive function, causal links to disorders like polycystic ovary syndrome (PCOS) and endometriosis remain unestablished. This study aimed to utilise Mendelian randomisation (MR) methods to explore causal associations between serum inflammatory markers and common reproductive disorders, aiming to identify novel mechanisms and potential avenues for treatment. Total causal effects of serum inflammatory markers (interleukins, monocyte chemoattractant protein-1, etc.) on female reproductive disorders in large sample cohorts of Finnish ancestry were assessed using univariable two-sample MR methods, including the inverse variance weighted (IVW) method as the primary analysis, with relevant quality assessments (e.g., leave-one out, heterogeneity, and horizontal pleiotropy testing). The main outcome measures were PCOS (642 cases and 118,228 controls) and endometriosis (8288 cases and 68,969 controls) from the FINNGEN cohort. Monocyte chemoattractant protein-1/C-C motif chemokine ligand demonstrated a positive causal association with polycystic ovary syndrome (odds ratio [95% CI]: 1.48 [1.10, 2.00], p = 0.0097), while higher interleukin-9 levels were positively associated with endometriosis (1.15 [1.02, 1.30], p = 0.0277), both via the IVW method. These markers should be investigated as key candidates for future research into the mechanistic pathways underpinning these conditions.

Keywords: endometriosis; inflammation; interleukins; mendelian randomisation; monocyte chemoattractant protein-1/C-C motif ligand-2 (MCP-1/CCL2); polycystic ovary syndrome (PCOS).

MeSH terms

  • Adult
  • Biomarkers* / blood
  • Chemokine CCL2 / blood
  • Chemokine CCL2 / genetics
  • Endometriosis* / blood
  • Endometriosis* / genetics
  • Female
  • Finland
  • Humans
  • Inflammation / blood
  • Inflammation / genetics
  • Mendelian Randomization Analysis*
  • Polycystic Ovary Syndrome* / blood
  • Polycystic Ovary Syndrome* / genetics

Substances

  • Biomarkers
  • Chemokine CCL2
  • CCL2 protein, human

Grants and funding

This research did not receive any dedicated funding. SA is supported by a Monash Graduate Research Scholarship from Monash University. HT and AM are supported by fellowships awarded by the National Health and Medical Research Council (NHMRC) of Australia (#1161871 and #2009326) and receive funding support from the NHMRC-funded Centre for Research Excellence in Women’s Health in Reproductive Life (CRE-WHiRL).